Buy Generic Clarithromycin Online

Generic Clarithromycin Information

Introduction

Clarithromycin is a macrolide antibiotic widely prescribed in the United Kingdom for a range of bacterial infections. The active compound—also called Clarithromycin—is classified within the antibiotics group and is manufactured by several global pharmaceutical companies, including Pfizer, which markets the original brand‑name formulation. In addition to treating respiratory and skin infections, Clarithromycin is employed as part of combination regimens for Helicobacter pylori eradication and for certain opportunistic infections in immunocompromised patients. Its oral availability, good tissue penetration, and relatively convenient dosing make it a common choice in primary‑care and secondary‑care settings across the UK.

What is Clarithromycin?

Clarithromycin is a semi‑synthetic derivative of erythromycin A, developed in the 198s to improve acid stability and gastrointestinal tolerability. It belongs to the macrolide class of antibiotics, which are characterised by a large lactone ring that interferes with bacterial protein synthesis. The drug is supplied in film‑coated tablets (250 mg and 500 mg) and as oral suspensions for paediatric use.

Clarithromycin is the generic version of Biaxin, containing the same active compound Clarithromycin. Our online pharmacy provides this generic alternative as a cost‑effective treatment option.

How Clarithromycin Works

Clarithromycin exerts its antibacterial effect by binding to the 50 S subunit of the bacterial ribosome. This binding blocks the translocation step of protein elongation, preventing the synthesis of essential proteins required for bacterial growth. At standard therapeutic concentrations the drug is primarily bacteriostatic, halting bacterial replication; however, at higher concentrations—particularly against susceptible organisms—it can become bactericidal.

After oral ingestion, Clarithromycin is rapidly absorbed (bioavailability ≈ 55 % fasting, ↑ to ≈ 70 % with food). Peak plasma levels occur within 2–3 hours, and the drug’s half‑life is approximately 3–4 hours in healthy adults. It is extensively metabolised by hepatic cytochrome P450 3A4 (CYP3A4) to an active metabolite, 14‑hydroxy‑Clarithromycin, which contributes to the overall antimicrobial activity. Excretion is mainly biliary, with ≈ 20 % eliminated unchanged in urine. These pharmacokinetic properties support twice‑daily dosing for most indications.

Conditions Treated with Clarithromycin

• Community‑acquired pneumonia (CAP) – Clarithromycin 500 mg twice daily for 7–10 days is a first‑line option for patients with atypical pathogens (e.g., Mycoplasma pneumoniae, Legionella spp.) when guideline‑directed therapy is required.
• Acute bacterial sinusitis – A 7‑day course of 250 mg twice daily targets Streptococcus pneumoniae and Haemophilus influenzae.
• Acute exacerbations of chronic bronchitis – The same 250 mg twice‑daily regimen improves symptom resolution and reduces treatment failure.
• Skin and soft‑tissue infections – Clarithromycin covers Staphylococcus aureus (including some macrolide‑sensitive strains) and streptococci, often prescribed for cellulitis or impetigo when penicillin allergy exists.
• Helicobacter pylori eradication – Used in triple therapy (Clarithromycin 500 mg twice daily combined with amoxicillin and a proton‑pump inhibitor) for 14 days, achieving > 80 % eradication rates in UK clinical trials.
• Mycobacterium avium complex (MAC) in HIV‑positive patients – Long‑term Clarithromycin (500 mg twice daily) in combination with ethambutol reduces disseminated disease, though this indication is now less common due to antiretroviral advances.

These conditions collectively represent a substantial portion of antibiotic prescribing in the UK. National data from Public Health England indicate that macrolides account for roughly 12 % of all oral antibiotics dispensed, underscoring Clarithromycin’s relevance in everyday practice.

Who is Clarithromycin For?

Clarithromycin is appropriate for adult patients who:

• Have a confirmed or strongly suspected bacterial infection in which macrolides are recommended by NICE or BNF guidelines.
• Require an oral antibiotic with reliable tissue penetration (e.g., lung, sinus, skin).
• Have a documented penicillin allergy, provided the allergy is not a severe anaphylactic reaction.

The drug is not suitable for:

• Patients with known hypersensitivity to macrolides or any of the tablet’s excipients.
• Individuals with significant hepatic impairment (Child‑Pugh class C) because metabolism is compromised.
• Those taking medications that strongly inhibit CYP3A4 (e.g., ketoconazole, ritonavir) without careful dose adjustment or monitoring.
• Patients with a history of QT‑prolongation, ventricular arrhythmias, or uncontrolled electrolyte disturbances.

Clinical judgment, together with an assessment of comorbidities and concurrent medicines, determines whether Clarithromycin is the optimal choice.

Risks, Side Effects, and Interactions

Common

• Gastro‑intestinal upset – nausea, abdominal discomfort, and dyspepsia occur in up to 15 % of users.
• Diarrhoea – often mild and self‑limiting; may be a sign of altered gut flora.
• Taste disturbance – a metallic or bitter taste is reported by 5‑10 % of patients.
• Headache – generally transient and resolves without intervention.

Rare

• Hepatobiliary effects – cholestatic jaundice and hepatic enzyme elevations have been observed, particularly with prolonged therapy.
• Cutaneous reactions – rash, pruritus, or photosensitivity may develop, usually within the first week.
• C. difficile infection – the risk of severe colitis is low but recognized, especially after broad‑spectrum antibiotic courses.

Serious

• QT interval prolongation and torsades de pointes – Clarithromycin can affect cardiac repolarisation; the risk increases with electrolyte imbalance or concurrent QT‑prolonging agents.
• Severe hypersensitivity – anaphylaxis, angio‑edema, or Stevens‑Johnson syndrome require immediate medical attention.
• Hepatic failure – rare cases of fulminant hepatitis have been reported, necessitating prompt discontinuation.

Clinically Relevant Drug–Drug Interactions

• CYP3A4 substrates – co‑administration with statins (simvastatin, lovastatin), calcium‑channel blockers, or certain benzodiazepines can raise plasma levels, increasing toxicity risk.
• Warfarin – Clarithromycin may potentiate anticoagulant effect; INR monitoring is advised.
• Ergot alkaloids – risk of ergotism (vasospasm, gangrene) is heightened; concomitant use is contraindicated.
• Pimozide – can cause severe QT prolongation; avoid combination.
• Carbamazepine and phenytoin – these enzyme inducers reduce Clarithromycin concentrations, potentially compromising efficacy.

Patients should provide a full medication list to their prescriber and pharmacist before initiating therapy.

Practical Use: Dosing, Missed Dose, Overdose

• Standard adult dosing –

  • Respiratory infections (CAP, sinusitis, bronchitis): 250 mg × 2 daily for 7–14 days; severe pneumonia may require 500 mg × 2 daily.
  • H. pylori eradication: 500 mg × 2 daily for 14 days in combination therapy.
  • MAC prophylaxis: 500 mg × 2 daily, continued for at least 12 months.

• Renal or hepatic impairment – No dosage reduction is required for mild to moderate renal dysfunction; severe hepatic impairment warrants a 50 % dose reduction and close monitoring.

• Missed dose – If a dose is forgotten, take it as soon as remembered unless the next scheduled dose is less than 4 hours away; in the latter case, skip the missed dose and resume the regular schedule. Never double‑dose.

• Overdose – Symptoms may include nausea, vomiting, abdominal pain, and dizziness. Management is primarily supportive: gastric lavage if presentation is early, activated charcoal, and monitoring of cardiac rhythm and hepatic function. No specific antidote exists.

• Food and alcohol – Clarithromycin can be taken with or without food; taking it with a meal may lessen gastrointestinal irritation. Alcohol does not directly interact with the drug but should be limited in patients with hepatic disease.

• Precautions – Avoid concurrent use of strong CYP3A4 inhibitors without dose adjustment. Counsel patients on the importance of completing the full prescribed course, even if symptoms improve early.

Buying Clarithromycin from Our Online Pharmacy

Clarithromycin can be purchased from our online pharmacy in the UK. Our service combines three key advantages:

• Affordability – Prices are close to manufacturer cost, offering a significant saving compared with many brick‑and‑mortar pharmacies.
• Verified Quality – We source the medication only from licensed overseas manufacturers that meet UK Medicines and Healthcare products Regulatory Agency (MHRA) standards.
• Reliable Delivery – Discreet, tracked shipping is provided; express options arrive within 7 days, while standard international airmail typically takes around 3 weeks.

Operating as a pharmacy broker service, we partner with overseas licensed pharmacies and suppliers to bring internationally recognised medicines to UK patients who might otherwise face limited access or higher out‑of‑pocket expenses. All orders are handled with strict privacy controls, ensuring that personal health information remains confidential throughout the transaction.

FAQ

• Is Clarithromycin available in both brand‑name and generic forms in the UK?
  Yes. The original brand‑name product is marketed as Biaxin, while numerous generic manufacturers sell the same active compound under the name Clarithromycin. The generic version provides the same therapeutic effect at a lower cost.

• What does a Clarithromycin tablet look like?
  The 250 mg film‑coated tablet is typically white, oval‑shaped, and imprinted with “250” on one side. The 500 mg tablet is larger, also white, and bears the imprint “500.” Tablet appearance may vary slightly between manufacturers but the active ingredient remains identical.

• Can Clarithromycin be stored in a hot climate, such as during summer travel?
  Clarithromycin should be kept at room temperature, below 30 °C (86 °F), and protected from direct sunlight. Prolonged exposure to high heat can accelerate degradation of the active compound, potentially reducing its potency.

• Does grapefruit juice affect Clarithromycin therapy?
  Grapefruit juice is a moderate inhibitor of CYP3A4, the enzyme that metabolises Clarithromycin. Consuming large amounts of grapefruit juice may increase Clarithromycin plasma concentrations, raising the risk of side effects such as QT prolongation. Patients are advised to limit grapefruit intake while on treatment.

• Are there any differences in formulation between Clarithromycin sold in Europe and the United States?
  European formulations often contain the excipient lactose as a filler, whereas some US products use mannitol. Both versions meet their respective regulatory standards, and the differences do not alter the drug’s antibacterial activity.

• Will taking Clarithromycin affect the results of a drug test?
  Clarithromycin is not a controlled substance and does not produce positive results on standard occupational drug screenings. However, its metabolites can occasionally be detected in specialized pharmacokinetic studies, which are not part of routine testing.

• Is Clarithromycin safe to use while breastfeeding?
  Small amounts of Clarithromycin are excreted in breast milk. Current evidence suggests it is compatible with breastfeeding, but infants should be monitored for possible gastrointestinal upset or allergic reactions. Consulting a healthcare professional is recommended before use.

• Can Clarithromycin reduce the effectiveness of hormonal contraceptives?
  Clarithromycin is a weak inhibitor of CYP3A4 and is not expected to significantly affect hormonal contraceptive levels. Nonetheless, if a patient is concurrently using other CYP3A4‑interacting drugs, a precautionary backup method of contraception may be considered.

• What is the shelf‑life of Clarithromycin tablets, and how should they be discarded after expiry?
  Unopened tablets typically retain potency for 24 months when stored as directed. Expired medication should be returned to a pharmacy take‑back scheme or disposed of in accordance with local hazardous waste regulations, rather than being thrown in household trash.

• How does Clarithromycin resistance impact its clinical use in the UK?
  Increasing macrolide resistance among Streptococcus pneumoniae and Mycoplasma genitalium has been reported, leading clinicians to reserve Clarithromycin for infections where susceptibility is confirmed or where alternative agents are unsuitable. Local microbiology data guide empirical prescribing decisions to preserve effectiveness.

Glossary

Macrolide

A class of antibiotics characterised by a large macrocyclic lactone ring; they inhibit bacterial protein synthesis by targeting the 50 S ribosomal subunit.

Cytochrome P450 3A4 (CYP3A4)

A liver enzyme responsible for metabolising many drugs, including Clarithromycin. Inhibitors or inducers of CYP3A4 can alter Clarithromycin plasma concentrations.

QT interval

A measurement on an electrocardiogram that represents the time for ventricular depolarisation and repolarisation. Prolongation can predispose to serious arrhythmias such as torsades de pointes.

Clostridioides difficile infection

A potentially severe colitis caused by overgrowth of C. difficile bacteria, often after disruption of normal gut flora by broad‑spectrum antibiotics.

⚠️ Disclaimer

The information provided about Clarithromycin is for general knowledge only. It does not replace professional medical consultation. All treatment decisions should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to Clarithromycin for individuals who may have limited availability through traditional pharmacies, prescription‑based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.